Tai‐Chung Tseng

6.3k total citations · 1 hit paper
166 papers, 4.1k citations indexed

About

Tai‐Chung Tseng is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Tai‐Chung Tseng has authored 166 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Epidemiology, 143 papers in Hepatology and 13 papers in Infectious Diseases. Recurrent topics in Tai‐Chung Tseng's work include Hepatitis C virus research (123 papers), Hepatitis B Virus Studies (119 papers) and Liver Disease Diagnosis and Treatment (118 papers). Tai‐Chung Tseng is often cited by papers focused on Hepatitis C virus research (123 papers), Hepatitis B Virus Studies (119 papers) and Liver Disease Diagnosis and Treatment (118 papers). Tai‐Chung Tseng collaborates with scholars based in Taiwan, United States and Australia. Tai‐Chung Tseng's co-authors include Jia‐Horng Kao, Chun‐Jen Liu, Pei‐Jer Chen, Tung‐Hung Su, Ding‐Shinn Chen, Chen‐Hua Liu, Hung‐Chih Yang, Chi‐Ling Chen, Stephanie Fang–Tzu Kuo and Chia‐Chi Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Tai‐Chung Tseng

157 papers receiving 4.0k citations

Hit Papers

High Levels of Hepatitis B Surface Antigen Increase Risk ... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
    2012 415 citations Tai‐Chung Tseng, Chun‐Jen Liu et al. Gastroenterology profile →

Peers

Tai‐Chung Tseng
Wan Cheng Chow Singapore
Chih‐Lin Lin Taiwan
Tatsuya Ide Japan
Liang‐Yen Wang Taiwan
Chin–Lan Jen Taiwan
Tawesak Tanwandee Thailand
David Sheridan United Kingdom
Michitami Yano Japan
Spilios Manolakopoulos Greece
Ming‐Yang Lai Taiwan
Wan Cheng Chow Singapore
Tai‐Chung Tseng
Citations per year, relative to Tai‐Chung Tseng Tai‐Chung Tseng (= 1×) peers Wan Cheng Chow

Countries citing papers authored by Tai‐Chung Tseng

Since Specialization
Citations

This map shows the geographic impact of Tai‐Chung Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tai‐Chung Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tai‐Chung Tseng more than expected).

Fields of papers citing papers by Tai‐Chung Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tai‐Chung Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tai‐Chung Tseng. The network helps show where Tai‐Chung Tseng may publish in the future.

Co-authorship network of co-authors of Tai‐Chung Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Tai‐Chung Tseng. A scholar is included among the top collaborators of Tai‐Chung Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tai‐Chung Tseng. Tai‐Chung Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tseng, Tai‐Chung, Yao‐Chun Hsu, Tung‐Hung Su, et al.. (2025). Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases. Journal of the Formosan Medical Association. 124(11). 1010–1017.
2.
Chang, Yu‐Ping, Jia‐Horng Kao, Tung‐Hung Su, et al.. (2025). Long-term serum ferritin dynamics in patients receiving antiviral treatment for hepatitis C virus infection. Journal of the Formosan Medical Association. 125(3). 283–290. 3 indexed citations
3.
Tseng, Tai‐Chung, Tetsuya Hosaka, Chun‐Jen Liu, et al.. (2025). Higher level of HBsAg associated with delayed development of HCC in immune-tolerant patients. Hepatology. 83(1). 142–155. 1 indexed citations
4.
Chen, Ya‐Fang, Cheng‐Hsuan Li, Ni‐Chung Lee, et al.. (2025). Plasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease. Annals of Clinical and Translational Neurology. 12(12). 2433–2445.
5.
Tseng, Tai‐Chung, Shang‐Chin Huang, Chun‐Jen Liu, et al.. (2025). Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold. Gut. 74(11). 1896–1904. 1 indexed citations
6.
Chang, Kai‐Chun, Tung‐Hung Su, Cho‐Kai Wu, et al.. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease is Associated with Increased Risks of Heart Failure. European Journal of Heart Failure. 27(3). 512–520. 12 indexed citations
7.
8.
Shao, Yu‐Yun, Tung‐Hung Su, Ming‐Chih Ho, et al.. (2025). Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial. British Journal of Cancer. 132(9). 822–827. 1 indexed citations
9.
Chang, Yu‐Ping, Tung‐Hung Su, Chun‐Jen Liu, et al.. (2024). Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping. Journal of Medical Virology. 96(5). e29686–e29686. 3 indexed citations
10.
Tseng, Tai‐Chung, Chun‐Jen Liu, Chun‐Ming Hong, et al.. (2023). Low Hepatitis B Core–Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels. Gastroenterology. 164(4). 669–679.e6. 13 indexed citations
11.
Tseng, Tai‐Chung, Tetsuya Hosaka, Chun‐Jen Liu, et al.. (2023). HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative. JHEP Reports. 6(1). 100956–100956. 5 indexed citations
12.
Lee, Ni‐Chung, Yin‐Hsiu Chien, Wuh‐Liang Hwu, et al.. (2023). Clinical Characteristics, Genetic Features, and Long-Term Outcome of Wilson’s Disease in a Taiwanese Population: An 11-Year Follow-Up Study. Journal of Movement Disorders. 16(2). 168–179. 4 indexed citations
13.
Su, Tung‐Hung, Shang‐Chin Huang, Tai‐Chung Tseng, et al.. (2023). Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria. Liver Cancer. 12(6). 539–549. 1 indexed citations
14.
Liu, Chen‐Hua, Hsin‐Yun Sun, Cheng‐Yuan Peng, et al.. (2022). Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open Forum Infectious Diseases. 9(8). ofac348–ofac348. 10 indexed citations
15.
16.
Tseng, Tai‐Chung, Chun‐Jen Liu, Wanting Yang, et al.. (2021). Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load. Alimentary Pharmacology & Therapeutics. 53(8). 908–918. 12 indexed citations
17.
Yang, Sheng‐Shun, Tung‐Hung Su, Hung‐Chih Yang, et al.. (2018). Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study. Journal of Hepatology. 68. S266–S266. 5 indexed citations
18.
Yang, Wanting, Liwei Wu, Tai‐Chung Tseng, et al.. (2016). Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. Medicine. 95(10). e2995–e2995. 14 indexed citations
19.
Tseng, Tai‐Chung, Chun‐Jen Liu, Hung‐Chih Yang, et al.. (2014). Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 64(2). 292–302. 84 indexed citations
20.
Tseng, Tai‐Chung, Chun‐Jen Liu, Tung‐Hung Su, et al.. (2012). Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation. The Journal of Infectious Diseases. 206(10). 1521–1531. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wan Cheng Chow Breakdown of academic impact, for papers by Chih‐Lin Lin Breakdown of academic impact, for papers by Tatsuya Ide Breakdown of academic impact, for papers by Liang‐Yen Wang Breakdown of academic impact, for papers by Chin–Lan Jen Breakdown of academic impact, for papers by Tawesak Tanwandee Breakdown of academic impact, for papers by David Sheridan Breakdown of academic impact, for papers by Michitami Yano Breakdown of academic impact, for papers by Spilios Manolakopoulos Breakdown of academic impact, for papers by Ming‐Yang Lai
Rankless by CCL
2026